Specify a stock or a cryptocurrency in the search bar to get a summary
Ginkgo Bioworks Holdings
DNAGinkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. Address: 27 Drydock Avenue, Boston, MA, United States, 02210
Analytics
WallStreet Target Price
8.8 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures DNA
Dividend Analytics DNA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DNA
Stock Valuation DNA
Financials DNA
Results | 2019 | Dynamics |